Media Center

Capital Increase 2017

4SC AG resolved to conduct a cash capital increase to raise funds to continue to advance its drug development programs for resminostat, 4SC-202 and 4SC-208.

Read more

Corporate News

Press releases on current events at 4SC.

Read news

Ad Hoc Announcements

Disclosure of inside information according to Article 17 MAR.

Read news

Photos & Logo

Management, theme images, logo

Watch photos


Share this page:

Follow us on: